CareFusion
Search results
BD is the one of the largest medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. For our associates, it means great opportunities for development and collaboration with colleagues across the globe to build products and solutions that impact the ...
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care.
3 days ago · At BD we believe in bringing your best, which is why we support you in being your best - inside and outside of work. From the comprehensive benefits packages we offer to the inclusive, encouraging environments our teams have built, you’ll be inspired to succeed and challenged to go even further.
For over 125 years, BD has been advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. We are a clear category leader, with key platforms in many large, foundational areas of healthcare and the global reach, and scale to address healthcare’s most pressing challenges.
Nov 12, 2021 · BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will begin its Investor Day at 8 a.m. ET today to share how it plans to leverage the breadth and depth...
Jun 20, 2024 · Discover the new BD. We create medical technology, devices and laboratory equipment for scores of different needs across the healthcare continuum. But we serve all of them with one single and relentless human purpose: advancing the world of health.
Aug 5, 2021 · BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.9 billion for the third fiscal quarter ended June 30, 2021. This represents a year-over-year increase of 26.9% on a reported basis and 22.0% on a currency-neutral basis.
Feb 3, 2022 · FRANKLIN LAKES, N.J., Feb. 3, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal year 2022, which ended December 31, 2021.
BD is a global medical technology company that is advancing the world of health TM by improving medical discovery, diagnostics and the delivery of care. 70,000+ BD Associates
